Asset 1

Biotech

We have one of the largest specialist biotech teams in Europe supporting global biotech companies at all stages of development, innovation, and growth. Our clients are diverse and include therapeutics companies, suppliers of research tools, companion diagnostics, and other in vitro diagnostics and bio information solutions. Our expertise extends to broader applications of biotech across environmental, industrial, and agri-biotech.

With legal expertise grounded in scientific know-how, our support incorporates company formation, spin-out accelerator programmes, venture capital fundraisings, licensing and collaborations, clinical trials, and strategic alliances in addition to accessing capital markets and deploying intellectual property rights.

Clients value our long-held industry connections and our specialist sector expertise. Our global team is embedded in this industry with experience across many technologies, including vaccines, therapeutic proteins, monoclonal antibodies, immune-oncology, and cell-based therapies, gene therapies, and tissue-engineered products.

We are chosen by renowned biotech companies for our expertise in negotiating on pivotal IP licensing deals, resolving disputes with strategic partners, dealing with data privacy issues and avoiding competition/anti-trust risks. With our support, they push innovation boundaries and exploit commercial opportunities while remaining secure within relevant regulatory regimes.

Scientist studying molecule model
Life sciences & healthcare

Paul England and Simon Cohen launch new life sciences IP guide

23 March 2021

by Paul England, DPhil and Simon Cohen

Click here to find out more
Genetically modified wheat growing in a petri dish
Life sciences & healthcare

Acting on transformational roll-up and $250 million crossover financing of cutting-edge UK and European biotech companies

16 February 2021

by Ross McNaughton and Colin McCall

Click here to find out more
Patterned pills
Life sciences & healthcare

Edison Open House Global Healthcare 2021 – key takeaways from our panel

4 February 2021
Quick read

by multiple authors

Click here to find out more
Pipette injecting liquid into microtiter plate on white background
Life sciences & healthcare

Will the UK government's COVID-19 dosing regime gamble pay off?

11 January 2021
Briefing

by Alison Dennis and Justyna Ostrowska

Click here to find out more

Related events

There are no upcoming events